<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Molecular Medicine Reports</journal-id>
<journal-title-group>
<journal-title>Molecular Medicine Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">1791-2997</issn>
<issn pub-type="epub">1791-3004</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/mmr.2019.10047</article-id>
<article-id pub-id-type="publisher-id">mmr-19-05-3707</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>1,25-Dihydroxy-Vitamin D3 induces macrophage polarization to M2 by upregulating T-cell Ig-mucin-3 expression</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Liang</surname><given-names>Shuyu</given-names></name>
<xref rid="af1-mmr-19-05-3707" ref-type="aff">1</xref>
<xref rid="c1-mmr-19-05-3707" ref-type="corresp"/></contrib>
<contrib contrib-type="author"><name><surname>Cai</surname><given-names>Jinzhen</given-names></name>
<xref rid="af2-mmr-19-05-3707" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author"><name><surname>Li</surname><given-names>Yani</given-names></name>
<xref rid="af1-mmr-19-05-3707" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Yang</surname><given-names>Rui</given-names></name>
<xref rid="af1-mmr-19-05-3707" ref-type="aff">1</xref></contrib>
</contrib-group>
<aff id="af1-mmr-19-05-3707"><label>1</label>Department of Pediatrics, Tianjin First Center Hospital, Tianjin 300192, P.R. China</aff>
<aff id="af2-mmr-19-05-3707"><label>2</label>Department of Transplantation Surgery, Tianjin First Center Hospital, Tianjin 300192, P.R. China</aff>
<author-notes>
<corresp id="c1-mmr-19-05-3707"><italic>Correspondence to</italic>: Dr Shuyu Liang, Department of Pediatrics, Tianjin First Center Hospital, 24 Fukang Road, Nankai, Tianjin 300192, P.R. China, E-mail: <email>shuyul_liang@163.com</email></corresp>
</author-notes>
<pub-date pub-type="ppub"><month>05</month><year>2019</year></pub-date>
<pub-date pub-type="epub"><day>15</day><month>03</month><year>2019</year></pub-date>
<volume>19</volume>
<issue>5</issue>
<fpage>3707</fpage>
<lpage>3713</lpage>
<history>
<date date-type="received"><day>22</day><month>05</month><year>2018</year></date>
<date date-type="accepted"><day>06</day><month>03</month><year>2019</year></date>
</history>
<permissions>
<copyright-statement>Copyright: &#x00A9; Liang et al.</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license>
</permissions>
<abstract>
<p>Macrophage polarization serves an important role in immune regulation that is regulated by T-cell immunoglobulin-mucin-3 (Tim-3). The objective of the present study was to explore the role of 1,25-dihydroxy-vitamin D3 [1,25(OH)<sub>2</sub>D3] in macrophage polarization. Plasmid transfection techniques were applied to prepare RAW264.7 cells with silenced or overexpressed Tim-3 gene. ELISAs were used to examine the level of inflammatory factors secreted by macrophages. Proteins levels were determined by western blot analysis. mRNAs expression levels were assessed using reverse transcription quantitative polymerase chain reaction. It was identified that 1,25(OH)<sub>2</sub>D3 upregulated Tim-3 levels and promoted the secretion of interleukin (IL)-10. 1,25(OH)<sub>2</sub>D3 was also observed to increase the level of transforming growth factor-&#x03B2; and to inhibit tumor necrosis factor-&#x03B1; and IL-6. The results also suggested that Tim-3 gene silencing induced macrophages polarization to classically activated macrophages (M1), and that overexpression of the Tim-3 gene induced macrophage polarization to alternatively activated macrophages (M2). 1,25(OH)<sub>2</sub>D3 treatment upregulated the expression level of Tim-3 in macrophages, which promoted cell polarization to M2 and inhibited polarization to M1. The data from the present study indicated that Tim-3 may induce macrophage polarization to M2, and that 1,25(OH)<sub>2</sub>D3 produced immunosuppressive effects by upregulating Tim-3.</p>
</abstract>
<kwd-group>
<kwd>macrophages</kwd>
<kwd>1,25-Dihydroxy-vitamin D3</kwd>
<kwd>T-cell immunogobulin-mucin-3</kwd>
<kwd>immunosuppression</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Autoimmune disorders are mediated by self-cells; that is, induced by the immune response to autoantigens (<xref rid="b1-mmr-19-05-3707" ref-type="bibr">1</xref>). Though common autoimmune disorders have high incidence rates, the pathogeneses of these diseases remain incompletely characterized (<xref rid="b2-mmr-19-05-3707" ref-type="bibr">2</xref>). At present, to the best of our knowledge, no drug has been identified to be sufficiently effective for the treatment of autoimmune diseases, and clinical therapy is largely based on symptomatic treatment and targeting the control of disease progression (<xref rid="b3-mmr-19-05-3707" ref-type="bibr">3</xref>&#x2013;<xref rid="b5-mmr-19-05-3707" ref-type="bibr">5</xref>). Therefore, exploring the pathogenesis of these diseases is of great significance in developing effective drugs and clinical strategies for the treatment of autoimmune diseases.</p>
<p>Vitamin D3 is a derivative of cholesterol and the most active form of Vitamin D3 is 1,25-dihydroxy-vitamin D3 [1,25(OH)<sub>2</sub>D3], formed by the action of hepatic microsomal 25-hydroxylase and kidney mitochondrial 1&#x03B1; hydroxylase (<xref rid="b6-mmr-19-05-3707" ref-type="bibr">6</xref>). Previous studies have demonstrated that abnormal levels of 1,25(OH)<sub>2</sub>D3 are closely associated with various autoimmune diseases (<xref rid="b7-mmr-19-05-3707" ref-type="bibr">7</xref>,<xref rid="b8-mmr-19-05-3707" ref-type="bibr">8</xref>). At present, studies investigating 1,25(OH)<sub>2</sub>D3 and immune function have attracted much attention. It has been identified that 1,25(OH)<sub>2</sub>D3 blocked the differentiation and maturation of dendritic cells (DCs) to promote T cell responses and differentiation (<xref rid="b9-mmr-19-05-3707" ref-type="bibr">9</xref>,<xref rid="b10-mmr-19-05-3707" ref-type="bibr">10</xref>). 1,25(OH)<sub>2</sub>D3 also promotes B lymphocyte-programmed death and inhibits the differentiation of activated B cells into plasma cells and memory B lymphocytes, which secrete immunoglobulins (<xref rid="b11-mmr-19-05-3707" ref-type="bibr">11</xref>,<xref rid="b12-mmr-19-05-3707" ref-type="bibr">12</xref>). However, only a limited number of studies have examined the macrophage polarization promoted by 1,25(OH)<sub>2</sub>D3.</p>
<p>It has been identified that 1,25(OH)<sub>2</sub>D3 promotes macrophage polarization: Macrophages are induced by tumor necrosis factor &#x03B1; (TNF-&#x03B1;) or interleukin-10 (IL-10) (<xref rid="b13-mmr-19-05-3707" ref-type="bibr">13</xref>,<xref rid="b14-mmr-19-05-3707" ref-type="bibr">14</xref>), and macrophage polarization to classically activated macrophages (M1) may assist in virus clearance and participate in inflammatory reactions; however, polarization of macrophages to alternatively activated macrophages (M2) may promote tumor development and inhibit inflammatory responses (<xref rid="b15-mmr-19-05-3707" ref-type="bibr">15</xref>,<xref rid="b16-mmr-19-05-3707" ref-type="bibr">16</xref>).</p>
<p>The polarization mechanism of macrophages has been studied extensively. T-cell Immunoglobulin-mucin-3 (Tim-3) was identified as a novel immunomodulatory protein (<xref rid="b17-mmr-19-05-3707" ref-type="bibr">17</xref>). Tim-3 has the function of regulating natural immune cells (<xref rid="b18-mmr-19-05-3707" ref-type="bibr">18</xref>). At present, previous studies have identified that Tim-3 may promote macrophage polarization to M2; however, its mechanism has not been fully described (<xref rid="b19-mmr-19-05-3707" ref-type="bibr">19</xref>,<xref rid="b20-mmr-19-05-3707" ref-type="bibr">20</xref>). Tim-3 belongs to the Tim protein family (<xref rid="b21-mmr-19-05-3707" ref-type="bibr">21</xref>). Previous studies have suggested that Tim-3 is significantly upregulated in chronic infectious diseases, including chronic Hepatitis C virus infection (<xref rid="b22-mmr-19-05-3707" ref-type="bibr">22</xref>), Human immunodeficiency virus infection (<xref rid="b23-mmr-19-05-3707" ref-type="bibr">23</xref>) and tuberculosis (<xref rid="b24-mmr-19-05-3707" ref-type="bibr">24</xref>) and downregulated in autoimmune diseases, including multiple sclerosis (<xref rid="b25-mmr-19-05-3707" ref-type="bibr">25</xref>) and rheumatoid arthritis (<xref rid="b17-mmr-19-05-3707" ref-type="bibr">17</xref>). Therefore, Tim-3 is considered to be included in a novel generation of immunomodulatory targets.</p>
<p>In the present study, genetic interference techniques were applied to explore the effect of 1,25(OH)<sub>2</sub>D3 on macrophages polarization, and its mechanism. The expression levels of polarization-associated factors with or without Tim-3 expression were detected. The results of the present study enrich the current understanding of the mechanisms underlying autoimmune diseases, and suggest alternative approaches for disease treatment.</p>
</sec>
<sec sec-type="materials|methods">
<title>Materials and methods</title>
<sec>
<title/>
<sec>
<title>Cells culture</title>
<p>The mouse macrophage RAW264.7 cell line was purchased from the American Type Culture Collection (Rockville, MD, USA). Cells were cultured in high-glucose Dulbecco&#x0027;s modified Eagle&#x0027;s medium (DMEM; Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) that contained 10&#x0025; fetal bovine serum (FBS; Gibco; Thermo Fisher Scientific, Inc.) with penicillin (100 U/ml) and streptomycin sulfate (100 &#x00B5;g/ml) at 37&#x00B0;C in an incubator with 5&#x0025; CO<sub>2</sub>. Culture reagents were purchased from Gibco (Thermo Fisher Scientific, Inc.).</p>
</sec>
<sec>
<title>Cell transfection</title>
<p>The recombinant Tim-3 overexpression plasmid (pTim-3), empty vector (pScramble) and small interfering (si)Tim-3 were purchased from Promega Corporation (Madison, WI, USA). The sequences of siTim-3 were Sense 5&#x2032;:GGUGUCUUAAUCCUUAAAU, and Antisense 3&#x2032;:CCACAGAAUUAGGAAUUUA. The cells were seeded at a density of 1&#x00D7;10<sup>4</sup> cells/well into a 24-well plate. The cells were then starved overnight by incubating them in DMEM without FBS prior to cell transfection. When the confluence reached 60&#x2013;70&#x0025;, the cells were transfected with pTim-3 or siTim-3 (50 pmol) using Lipofectamine<sup>&#x00AE;</sup> 3000 (Invitrogen; Thermo Fisher Scientific, Inc.), according to the protocol of the manufacturer. The time interval between transfection and subsequent experimentation was 24 h. For screening the positive clones, the RAW264.7 cell line with the stable knockdown or Tim-3 overexpression plasmid was cultured in the aforementioned complete medium with 200 and 700 &#x00B5;g/ml G418 respectively, at 37&#x00B0;C for 24 h. According to data from previous studies (<xref rid="b26-mmr-19-05-3707" ref-type="bibr">26</xref>&#x2013;<xref rid="b28-mmr-19-05-3707" ref-type="bibr">28</xref>), 10<sup>&#x2212;8</sup> or 10<sup>&#x2212;7</sup> M 1,25(OH)<sub>2</sub>D3 was used to treat the RAW264.7 cells for 3 days. Cell morphology was observed using a laser confocal microscope, with magnifications &#x00D7;100 and &#x00D7;200 (Leica TCS SP8; Leica Microsystems, Wetzlar, Germany).</p>
</sec>
<sec>
<title>ELISAs</title>
<p>ELISAs were used to measure the concentrations of TNF-&#x03B1;, IL-6, IL-10 and transforming growth factor-&#x03B2; (TGF-&#x03B2;). The kits were Mouse TNF-&#x03B1; Quantikine ELISA Kit (MTA00B, R&#x0026;D Systems, Inc., Minneapolis, MN, USA), Mouse IL-6 Quantikine ELISA Kit (M6000B, R&#x0026;D), Mouse IL-10 Quantikine ELISA Kit (M1000B, R&#x0026;D), and Mouse/Rat/Porcine/Canine TGF-beta 1 Quantikine ELISA Kit (MB100B, R&#x0026;D). Following washing, blocking solution was added at 4&#x00B0;C and incubated for 2 h. Next, the primary antibody was added at 4&#x00B0;C and incubated overnight. The secondary antibody was then added and incubated for 1 h at room temperature. Horseradish peroxidase was added dropwise for 30 min at room temperature, and then tetramethylbenzidine was added for 10 min. The absorbance value was measured at 450 nm using a microplate reader (ELX 800; Bio-Tek Instruments, Winooski, VT, USA) and the concentration was calculated following the standard curve.</p>
</sec>
<sec>
<title>Western blot analysis</title>
<p>The expression levels of Tim-3, nitric oxide synthase, inducible (NOS2) and macrophage mannose receptor 1 (COD206) proteins were detected using western blot analysis. Cells were lysed with liquid nitrogen and radioimmunoprecipitation assay lysis buffer (Abmole Bioscience Inc., Houston, TX, USA). Next, the cells were cleaved with 1&#x0025; phenylmethyl sulfonyl fluoride mixed with phosphatase inhibitors (Abmole Bioscience Inc) for 30 min at 4&#x00B0;C. The supernatant was collected using centrifugation at 13,000 &#x00D7; g at 4&#x00B0;C for 15 min. A standard curve was drawn using the BCA method to determine the protein concentration. Then, proteins (20 &#x00B5;g/lane) were separated using 10&#x0025; SDS-PAGE gels, and transferred to polyvinylidene difluoride (PVDF) membranes (Bio-Rad Laboratories, Inc., Hercules, CA, USA) using a Trans-Blot Transfer Slot (Bio-Rad Laboratories, Inc.). The PVDF membranes were then blocked with 5&#x0025; skimmed milk for 2 h at room temperature. Primary antibodies against Tim-3 (cat. no. ab185703; 1:800; Abcam, Cambridge, MA, USA), NOS2 (cat. no. 14-5920-80; 1:800; eBioscience; Thermo Fisher Scientific, Inc.), CD206 (cat. no. 141703; 1:600; BioLegend, Inc., San Diego, CA, USA) were then added according to the manufacturers&#x0027; protocols. The samples were agitated at room temperature for 2 h and then incubated at 4&#x00B0;C for 12 h. Rabbit anti-mouse IgG (cat. no. ab99697; 1:9,000 Abcam), mouse anti-rabbit IgG (cat. no. BA1034; 1:1,000; Invitrogen; Thermo Fisher Scientific, Inc.) and goat anti-mouse IgG (cat. no. ab6785; 1:8,000; Abcam) HRP-conjugated secondary antibodies were added and incubated at room temperature for 1.5 h. Chemiluminescence detection was performed using ECL reagent (EMD Millipore, Billerica, MA, USA). The densitometric analysis was performed using Bio-Rad ChemiDoc&#x2122; XRS&#x002B; System with Image Lab&#x2122; Software version 4.1 (Bio-Rad Laboratories, Inc., Hercules, CA, USA).</p>
</sec>
<sec>
<title>Reverse transcription quantitative polymerase chain reaction (RT-qPCR) analysis</title>
<p>RT-qPCR was performed to determine the mRNA levels of Tim-3, NOS2 and COD206. The cells were triturated and lysed by TRIzol<sup>&#x00AE;</sup> (Thermo Fisher Scientific, Inc.) at 0&#x00B0;C for 5 min. RNA was then extracted using CCl<sub>3</sub> (Shanghai Aladdin Biochemical Technology Co., Ltd., Shanghai, China) and dissolved in diethyl pyrocarbonate-treated water (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany). RNA concentration was measured using a UV NanoDrop One Microvolume UV&#x2013;Vis spectrophotometer (Thermo Fisher Scientific, Inc., Wilmington, DE, USA). Reverse transcription assays were performed on RNA samples to synthesize cDNA using a reverse transcription kit (Takara Biotechnology, Co., Ltd., Dalian, China). The samples were incubated at 37&#x00B0;C for 15 min, followed by heat inactivation at 85&#x00B0;C for 15 sec. RT-qPCR experiments were performed using the SYBR Prellix Ex Taq&#x2122; Real-Time PCR kit (Takara Biotechnology, Co., Ltd.). qPCR was performed by activating the DNA polymerase at 95&#x00B0;C for 5 min, which was followed by 40 cycles of a two-step PCR (at 95&#x00B0;C for 10 sec and at 60&#x00B0;C for 30 sec) with a final extension step at 75&#x00B0;C for 10 min. Samples were then held at 4&#x00B0;C. &#x03B2;-actin was used as an internal control. All primers were purchased from Genewiz, Inc., (Suzhou, Jiangsu China), and are summarized in <xref rid="tI-mmr-19-05-3707" ref-type="table">Table I</xref>. The 2<sup>&#x2212;&#x0394;&#x0394;Cq</sup> method was used to quantify the gene expression levels (<xref rid="b29-mmr-19-05-3707" ref-type="bibr">29</xref>).</p>
</sec>
<sec>
<title>Statistical analysis</title>
<p>All experimental data are presented as means &#x00B1; standard deviation. Statistical analysis was performed using SPSS 20 (IBM Corp., Armonk, NY, USA). The one-way analysis of variance followed by Tukey&#x0027;s multiple comparison post-hoc test was performed to analyze the differences among experimental groups. P<italic>&#x003C;</italic>0.05 was considered to indicate a statistically significant difference.</p>
</sec>
</sec>
</sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title/>
<sec>
<title>Confocal microscopy</title>
<p>The viable RAW264.7 macrophages were normal at magnifications, &#x00D7;100 and &#x00D7;200 (<xref rid="f1-mmr-19-05-3707" ref-type="fig">Fig. 1</xref>).</p>
</sec>
<sec>
<title>1,25(OH)<sub>2</sub>D3 regulates the secretion of inflammatory cytokines in RAW264.7 cell</title>
<p>It was identified that the levels of TNF-&#x03B1; and IL-6 secreted by RAW264.7 cells were decreased in the presence of 1,25(OH)<sub>2</sub>D3. However, the levels of IL-10 and TGF-&#x03B2; were increased (P&#x003C;0.01; <xref rid="f2-mmr-19-05-3707" ref-type="fig">Fig. 2A-D</xref>). These differences were the most significant at concentrations of 10<sup>&#x2212;7</sup> M (P&#x003C;0.05).</p>
</sec>
<sec>
<title>1,25(OH)<sub>2</sub>D3 upregulates Tim-3 expression</title>
<p>To investigate the mechanism of how 1,25 (OH)<sub>2</sub>D3 affects the expression levels of inflammatory factors, levels of Tim-3, and NOS2 and COD206, the markers of M1 and M2, were examined. The results indicated that the expression level of Tim-3 was gradually increased in the 10<sup>&#x2212;8</sup> M and 10<sup>&#x2212;7</sup> M groups. However, whilst 1,25 (OH)<sub>2</sub>D3 did not affect the expressions of the NOS2 and COD206, it decreased NOS2 mRNA levels (P&#x003C;0.05; <xref rid="f2-mmr-19-05-3707" ref-type="fig">Fig. 2E-K</xref>). This observation indicated that 1,25(OH)<sub>2</sub>D3 promoted Tim-3 expression in a dose-dependent manner.</p>
</sec>
<sec>
<title>Effects of Tim-3 gene silencing on cytokines</title>
<p>Following silencing of the Tim-3 gene, the levels of TNF-&#x03B1; and IL-6 secreted by RAW264.7 cells were upregulated, while the levels of IL-10 and TGF-&#x03B2; were downregulated (P&#x003C;0.01; <xref rid="f3-mmr-19-05-3707" ref-type="fig">Fig. 3A-D</xref>). Following the decrease of the Tim-3 gene expression, the mRNA and protein expression levels of NOS2 were observed increased compared with that of the NC and control groups, while the expression levels of CD206 mRNA and protein were significantly decreased (P&#x003C;0.01; <xref rid="f3-mmr-19-05-3707" ref-type="fig">Fig. 3E-K</xref>). This phenomenon suggested that silence of Tim-3 gene promoted the polarization of macrophages to M1.</p>
</sec>
<sec>
<title>Effects of overexpression of Tim-3 on cytokines</title>
<p>The effects of the overexpression of Tim-3 on cytokines were also examined. It was identified that the levels of TNF-&#x03B1; and IL-6 in the pTim-3 group were decreased compared with those in the NC group, and that the levels of IL-10 and TGF-&#x03B2; were increased compared with those in the NC group (P&#x003C;0.01; <xref rid="f4-mmr-19-05-3707" ref-type="fig">Fig. 4A-D</xref>). When Tim-3 was overexpressed, the mRNA and protein expression levels of NOS2 were decreased, while the expression levels of CD206 mRNA and protein were increased (P&#x003C;0.01; <xref rid="f4-mmr-19-05-3707" ref-type="fig">Fig. 4E-K</xref>). This suggested that the overexpression of Tim-3 promoted the polarization of macrophages to M2.</p>
</sec>
<sec>
<title>Effects of 1,25(OH)<sub>2</sub>D3 on cytokine under Tim-3 silencing or overexpression conditions</title>
<p>To additionally explore the effect of 1,25(OH)2D3 on the polarization of macrophages, RAW264.7 cells were cultured in the presence of 10<sup>&#x2212;7</sup> M 1,25(OH)<sub>2</sub>D3. The expression levels of inflammatory factors, and M1 and M2 marker proteins NOS2 and CD206, were detected.</p>
<p>It was identified that 1,25(OH)2D3 downregulated the levels of TNF-&#x03B1; and IL-6 and upregulated the level of TGF-&#x03B2; in siTim-3 cells. In addition, 1,25(OH)<sub>2</sub>D3 promoted the expression of Tim-3 and increased the expression levels of CD206 protein in siTim-3 cells. However, 1,25(OH)<sub>2</sub>D3 decreased the expression levels of NOS2. For RAW264.7 cells with stable overexpression of Tim-3, 1,25(OH)2D3 was observed to additionally decrease TNF-&#x03B1; and IL-6 levels and increase IL-10 and TGF-&#x03B2; levels, compared to the Tim-3 overexpression group. In addition, 1,25 (OH)<sub>2</sub>D3 increased the level of Tim-3 and the expression levels of CD206 in RAW264.7 cell with stable expression of Tim-3 gene (<xref rid="f5-mmr-19-05-3707" ref-type="fig">Fig. 5A-K</xref>). This indicated that 1,25(OH)<sub>2</sub>D3 promoted the polarization of macrophages to M2 and inhibited polarization of macrophages to M1 via upregulating the expression of Tim-3.</p>
</sec>
</sec>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>Macrophages may be induced to polarize to M1 or M2 subtypes by different cytokines, and also secrete different cytokines to promote or suppress the immune response (<xref rid="b30-mmr-19-05-3707" ref-type="bibr">30</xref>). Macrophage cells may also maintain the homeostasis and serve an important role in the formation and treatment of diseases (<xref rid="b31-mmr-19-05-3707" ref-type="bibr">31</xref>).</p>
<p>It has been identified that Vitamin D3 has immunomodulatory effects on chicken macrophages (<xref rid="b32-mmr-19-05-3707" ref-type="bibr">32</xref>). Yin <italic>et al</italic> (<xref rid="b33-mmr-19-05-3707" ref-type="bibr">33</xref>) also revealed that Vitamin D may induce macrophage polarization by activating CYP27A1 to prevent atherosclerosis in hypercholesterolemic animals. The present study demonstrated that 1,25(OH)<sub>2</sub>D3 inhibited TNF-&#x03B1; and IL-6 and promoted the secretion of IL-10 and TGF-&#x03B2;. TNF-&#x03B1; induces macrophage polarization to M1 and the secretion of TNF-&#x03B1; and IL-6. IL-10 induces macrophage polarization to M2 and secretion of IL-10 and TGF-&#x03B2; (<xref rid="b13-mmr-19-05-3707" ref-type="bibr">13</xref>,<xref rid="b14-mmr-19-05-3707" ref-type="bibr">14</xref>). The results of the present study indicated that 1,25(OH)<sub>2</sub>D3 decreased the level of NOS2 mRNA, but did not produce a significant effect on NOS2 protein expression or CD206 protein and mRNA expression. However, the expression of Tim-3 was increased by 1,25(OH)<sub>2</sub>D3. Tim-3 serves a role in modulating immunity (<xref rid="b34-mmr-19-05-3707" ref-type="bibr">34</xref>), through inducing macrophage polarization. This suggests that 1,25(OH)<sub>2</sub>D3 may regulate macrophage polarization through Tim-3. Therefore, the effect of 1,25(OH)<sub>2</sub>D3 on macrophages was investigated through silencing or overexpressing Tim-3. The results demonstrate that silencing of the Tim-3 gene may promote the secretion of TNF-&#x03B1; and IL-6 but inhibit the secretion of IL-10 and TGF-&#x03B2;. In addition, downregulation of Tim-3 increased the protein and mRNA levels of NOS2 and decreased the protein and mRNA levels of the M2 marker CD206. By contrast, overexpression of the Tim-3 gene exerted the opposite effects This is consistent with previous data (<xref rid="b17-mmr-19-05-3707" ref-type="bibr">17</xref>,<xref rid="b22-mmr-19-05-3707" ref-type="bibr">22</xref>&#x2013;<xref rid="b25-mmr-19-05-3707" ref-type="bibr">25</xref>), indicating that a high expression level of Tim-3 gene promotes macrophage polarization to M2 and produces immunosuppressive effects. Therefore, we hypothesized that 1,25(OH)<sub>2</sub>D3 may induce cell polarization to M2 by upregulating Tim-3 expression and exerting immunosuppressive effects.</p>
<p>The role of 1,25(OH)<sub>2</sub>D3 in macrophages polarization was also explored. The data indicated that the decreased levels of IL-6 and TNF-&#x03B1; and the increased IL-10 and TGF-&#x03B2; were reversed in the presence of siTim-3. However, the effect of 1,25(OH)<sub>2</sub>D3 was enhanced by the overexpression of Tim-3. This suggested that 1,25(OH)<sub>2</sub>D3 produced an immunosuppressive effect by promoting Tim-3 protein. It was consistent with a previous study, in which 1,25(OH)2D3 was identified to induce macrophage polarization to M2, leading to immunosuppression (<xref rid="b33-mmr-19-05-3707" ref-type="bibr">33</xref>).</p>
<p>However, the mechanism underlying the regulation of Tim-3 protein levels by 1,25(OH)<sub>2</sub>D3 remains unclear. An additional limitation of the present study is that RAW264.7 is a cancerous macrophage cell line, as opposed to a primary cell line. Therefore, additional investigation in primary cells or <italic>in vivo</italic> experiments would strengthen the results of the present study. Altogether, the mechanism for the regulation of M1/M2 conversion and inflammation by Tim-3 remains to be determined.</p>
<p>In summary, Tim-3 induces macrophage polarization to M2. 1,25(OH)<sub>2</sub>D3 exhibited immunosuppressive effects by upregulating Tim-3 protein levels. The present study suggested that 1,25(OH)<sub>2</sub>D3 may serve as an immunosuppressive drug and that Tim-3 may be a potential target in treating autoimmune diseases.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>Not applicable.</p>
</ack>
<sec>
<title>Funding</title>
<p>No funding was received.</p>
</sec>
<sec>
<title>Availability of data and materials</title>
<p>The analyzed data sets generated during the study are available from the corresponding author on reasonable request.</p>
</sec>
<sec>
<title>Authors&#x0027; contributions</title>
<p>SL and JC did all of the experiments, YL analyzed the data, RY designed the study, and SL wrote the manuscript.</p>
</sec>
<sec>
<title>Ethics approval and consent to participate</title>
<p>Not applicable.</p>
</sec>
<sec>
<title>Patient consent for publication</title>
<p>Not applicable.</p>
</sec>
<sec>
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="b1-mmr-19-05-3707"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benros</surname><given-names>ME</given-names></name><name><surname>Waltoft</surname><given-names>BL</given-names></name><name><surname>Nordentoft</surname><given-names>M</given-names></name><name><surname>Ostergaard</surname><given-names>SD</given-names></name><name><surname>Eaton</surname><given-names>WW</given-names></name><name><surname>Krogh</surname><given-names>J</given-names></name><name><surname>Mortensen</surname><given-names>PB</given-names></name></person-group><article-title>Autoimmune diseases and severe infections as risk factors for mood disorders: A nationwide study</article-title><source>JAMA Psychiatry</source><volume>70</volume><fpage>812</fpage><lpage>820</lpage><year>2013</year><pub-id pub-id-type="doi">10.1001/jamapsychiatry.2013.1111</pub-id><pub-id pub-id-type="pmid">23760347</pub-id></element-citation></ref>
<ref id="b2-mmr-19-05-3707"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>SW</given-names></name><name><surname>Zhong</surname><given-names>XS</given-names></name><name><surname>Jiang</surname><given-names>LN</given-names></name><name><surname>Zheng</surname><given-names>XY</given-names></name><name><surname>Xiong</surname><given-names>YQ</given-names></name><name><surname>Ma</surname><given-names>SJ</given-names></name><name><surname>Qiu</surname><given-names>M</given-names></name><name><surname>Huo</surname><given-names>ST</given-names></name><name><surname>Ge</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name></person-group><article-title>Maternal autoimmune diseases and the risk of autism spectrum disorders in offspring: A systematic review and meta-analysis</article-title><source>Behav Brain Res</source><volume>296</volume><fpage>61</fpage><lpage>69</lpage><year>2016</year><pub-id pub-id-type="doi">10.1016/j.bbr.2015.08.035</pub-id><pub-id pub-id-type="pmid">26327239</pub-id></element-citation></ref>
<ref id="b3-mmr-19-05-3707"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iyer</surname><given-names>A</given-names></name><name><surname>Elsone</surname><given-names>L</given-names></name><name><surname>Appleton</surname><given-names>R</given-names></name><name><surname>Jacob</surname><given-names>A</given-names></name></person-group><article-title>A review of the current literature and a guide to the early diagnosis of autoimmune disorders associated with neuromyelitis optica</article-title><source>Autoimmunity</source><volume>47</volume><fpage>154</fpage><lpage>161</lpage><year>2014</year><pub-id pub-id-type="doi">10.3109/08916934.2014.883501</pub-id><pub-id pub-id-type="pmid">24512514</pub-id></element-citation></ref>
<ref id="b4-mmr-19-05-3707"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nielsen</surname><given-names>PR</given-names></name><name><surname>Benros</surname><given-names>ME</given-names></name><name><surname>Dalsgaard</surname><given-names>S</given-names></name></person-group><article-title>Associations between autoimmune diseases and attention-deficit/hyperactivity disorder: A nationwide study</article-title><source>J Am Acad Child Adolesc Psychiatry</source><volume>56</volume><fpage>234</fpage><lpage>240.e231</lpage><year>2017</year><pub-id pub-id-type="doi">10.1016/j.jaac.2016.12.010</pub-id><pub-id pub-id-type="pmid">28219489</pub-id></element-citation></ref>
<ref id="b5-mmr-19-05-3707"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersson</surname><given-names>NW</given-names></name><name><surname>Gustafsson</surname><given-names>LN</given-names></name><name><surname>Okkels</surname><given-names>N</given-names></name><name><surname>Taha</surname><given-names>F</given-names></name><name><surname>Cole</surname><given-names>SW</given-names></name><name><surname>Munk-Jorgensen</surname><given-names>P</given-names></name><name><surname>Goodwin</surname><given-names>RD</given-names></name></person-group><article-title>Depression and the risk of autoimmune disease: A nationally representative, prospective longitudinal study</article-title><source>Psychol Med</source><volume>45</volume><fpage>3559</fpage><lpage>3569</lpage><year>2015</year><pub-id pub-id-type="doi">10.1017/S0033291715001488</pub-id><pub-id pub-id-type="pmid">26271451</pub-id></element-citation></ref>
<ref id="b6-mmr-19-05-3707"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ota</surname><given-names>K</given-names></name><name><surname>Dambaeva</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>MW</given-names></name><name><surname>Han</surname><given-names>AR</given-names></name><name><surname>Fukui</surname><given-names>A</given-names></name><name><surname>Gilman-Sachs</surname><given-names>A</given-names></name><name><surname>Beaman</surname><given-names>K</given-names></name><name><surname>Kwak-Kim</surname><given-names>J</given-names></name></person-group><article-title>1,25-Dihydroxy-vitamin D3 regulates NK-cell cytotoxicity, cytokine secretion, and degranulation in women with recurrent pregnancy losses</article-title><source>Eur J Immunol</source><volume>45</volume><fpage>3188</fpage><lpage>3199</lpage><year>2015</year><pub-id pub-id-type="doi">10.1002/eji.201545541</pub-id><pub-id pub-id-type="pmid">26257123</pub-id></element-citation></ref>
<ref id="b7-mmr-19-05-3707"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alhassan Mohammed</surname><given-names>H</given-names></name><name><surname>Saboor-Yaraghi</surname><given-names>AA</given-names></name><name><surname>Mirshafiey</surname><given-names>A</given-names></name><name><surname>Vahedi</surname><given-names>H</given-names></name><name><surname>Shiri-Shahsavar</surname><given-names>MR</given-names></name><name><surname>Mousavi Nasl Khameneh</surname><given-names>A</given-names></name></person-group><article-title>Immunomodulatory and immunosuppressive roles of 1&#x03B1;,25(OH)2D3 in autoimmune diseases</article-title><source>Scand J Immunol</source><volume>85</volume><fpage>95</fpage><lpage>103</lpage><year>2017</year><pub-id pub-id-type="doi">10.1111/sji.12512</pub-id><pub-id pub-id-type="pmid">27896829</pub-id></element-citation></ref>
<ref id="b8-mmr-19-05-3707"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fitch</surname><given-names>N</given-names></name><name><surname>Becker</surname><given-names>AB</given-names></name><name><surname>HayGlass</surname><given-names>KT</given-names></name></person-group><article-title>Vitamin D [1,25(OH)2D3] differentially regulates human innate cytokine responses to bacterial versus viral pattern recognition receptor stimuli</article-title><source>J Immunol</source><volume>196</volume><fpage>2965</fpage><lpage>2972</lpage><year>2016</year><pub-id pub-id-type="doi">10.4049/jimmunol.1500460</pub-id><pub-id pub-id-type="pmid">26895836</pub-id></element-citation></ref>
<ref id="b9-mmr-19-05-3707"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferreira</surname><given-names>GB</given-names></name><name><surname>Gysemans</surname><given-names>CA</given-names></name><name><surname>Demengeot</surname><given-names>J</given-names></name><name><surname>da Cunha</surname><given-names>JP</given-names></name><name><surname>Vanherwegen</surname><given-names>AS</given-names></name><name><surname>Overbergh</surname><given-names>L</given-names></name><name><surname>Van Belle</surname><given-names>TL</given-names></name><name><surname>Pauwels</surname><given-names>F</given-names></name><name><surname>Verstuyf</surname><given-names>A</given-names></name><name><surname>Korf</surname><given-names>H</given-names></name><name><surname>Mathieu</surname><given-names>C</given-names></name></person-group><article-title>1,25-Dihydroxyvitamin D3 promotes tolerogenic dendritic cells with functional migratory properties in NOD mice</article-title><source>J Immunol</source><volume>192</volume><fpage>4210</fpage><lpage>4220</lpage><year>2014</year><pub-id pub-id-type="doi">10.4049/jimmunol.1302350</pub-id><pub-id pub-id-type="pmid">24663679</pub-id></element-citation></ref>
<ref id="b10-mmr-19-05-3707"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ria</surname><given-names>F</given-names></name><name><surname>Penna</surname><given-names>G</given-names></name><name><surname>Adorini</surname><given-names>L</given-names></name></person-group><article-title>Th1 cells induce and Th2 inhibit antigen-dependent IL-12 secretion by dendritic cells</article-title><source>Eur J Immunol</source><volume>28</volume><fpage>2003</fpage><lpage>2016</lpage><year>1998</year><pub-id pub-id-type="doi">10.1002/(SICI)1521-4141(199806)28:06&#x003C;2003::AID-IMMU2003&#x003E;3.0.CO;2-S</pub-id><pub-id pub-id-type="pmid">9645382</pub-id></element-citation></ref>
<ref id="b11-mmr-19-05-3707"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sergeev</surname><given-names>IN</given-names></name><name><surname>Pletsityi</surname><given-names>KD</given-names></name><name><surname>Rusnak</surname><given-names>FI</given-names></name><name><surname>Spirichev</surname><given-names>VB</given-names></name></person-group><article-title>1,25-Dihydroxyvitamin D3 receptors in lymphocytes and T- and B-lymphocyte count in patients with glomerulonephritis</article-title><source>Vopr Med Khim</source><volume>35</volume><fpage>117</fpage><lpage>121</lpage><year>1989</year><comment>(In Russian)</comment><pub-id pub-id-type="pmid">2560867</pub-id></element-citation></ref>
<ref id="b12-mmr-19-05-3707"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geldmeyer-Hilt</surname><given-names>K</given-names></name><name><surname>Heine</surname><given-names>G</given-names></name><name><surname>Hartmann</surname><given-names>B</given-names></name><name><surname>Baumgrass</surname><given-names>R</given-names></name><name><surname>Radbruch</surname><given-names>A</given-names></name><name><surname>Worm</surname><given-names>M</given-names></name></person-group><article-title>1,25-dihydroxyvitamin D3 impairs NF-kappaB activation in human naive B cells</article-title><source>Biochem Biophys Res Commun</source><volume>407</volume><fpage>699</fpage><lpage>702</lpage><year>2011</year><pub-id pub-id-type="doi">10.1016/j.bbrc.2011.03.078</pub-id><pub-id pub-id-type="pmid">21420936</pub-id></element-citation></ref>
<ref id="b13-mmr-19-05-3707"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>LC</given-names></name><name><surname>Jenkins</surname><given-names>SJ</given-names></name><name><surname>Allen</surname><given-names>JE</given-names></name><name><surname>Taylor</surname><given-names>PR</given-names></name></person-group><article-title>Tissue-resident macrophages</article-title><source>Nat Immunol</source><volume>14</volume><fpage>986</fpage><lpage>995</lpage><year>2013</year><pub-id pub-id-type="doi">10.1038/ni.2705</pub-id><pub-id pub-id-type="pmid">24048120</pub-id><pub-id pub-id-type="pmcid">4045180</pub-id></element-citation></ref>
<ref id="b14-mmr-19-05-3707"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wynn</surname><given-names>TA</given-names></name><name><surname>Chawla</surname><given-names>A</given-names></name><name><surname>Pollard</surname><given-names>JW</given-names></name></person-group><article-title>Macrophage biology in development, homeostasis and disease</article-title><source>Nature</source><volume>496</volume><fpage>445</fpage><lpage>455</lpage><year>2013</year><pub-id pub-id-type="doi">10.1038/nature12034</pub-id><pub-id pub-id-type="pmid">23619691</pub-id><pub-id pub-id-type="pmcid">3725458</pub-id></element-citation></ref>
<ref id="b15-mmr-19-05-3707"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jablonski</surname><given-names>KA</given-names></name><name><surname>Amici</surname><given-names>SA</given-names></name><name><surname>Webb</surname><given-names>LM</given-names></name><name><surname>Ruiz-Rosado Jde</surname><given-names>D</given-names></name><name><surname>Popovich</surname><given-names>PG</given-names></name><name><surname>Partida-Sanchez</surname><given-names>S</given-names></name><name><surname>Guerau-de-Arellano</surname><given-names>M</given-names></name></person-group><article-title>Novel markers to delineate murine M1 and M2 macrophages</article-title><source>PLoS One</source><volume>10</volume><fpage>e0145342</fpage><year>2015</year><pub-id pub-id-type="doi">10.1371/journal.pone.0145342</pub-id><pub-id pub-id-type="pmid">26699615</pub-id><pub-id pub-id-type="pmcid">4689374</pub-id></element-citation></ref>
<ref id="b16-mmr-19-05-3707"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cucak</surname><given-names>H</given-names></name><name><surname>Grunnet</surname><given-names>LG</given-names></name><name><surname>Rosendahl</surname><given-names>A</given-names></name></person-group><article-title>Accumulation of M1-like macrophages in type 2 diabetic islets is followed by a systemic shift in macrophage polarization</article-title><source>J Leukoc Biol</source><volume>95</volume><fpage>149</fpage><lpage>160</lpage><year>2014</year><pub-id pub-id-type="doi">10.1189/jlb.0213075</pub-id><pub-id pub-id-type="pmid">24009176</pub-id></element-citation></ref>
<ref id="b17-mmr-19-05-3707"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>EJ</given-names></name><name><surname>Noh</surname><given-names>JW</given-names></name><name><surname>Hwang</surname><given-names>JW</given-names></name><name><surname>Bae</surname><given-names>EK</given-names></name><name><surname>Ahn</surname><given-names>JK</given-names></name><name><surname>Koh</surname><given-names>EM</given-names></name><name><surname>Cha</surname><given-names>HS</given-names></name></person-group><article-title>Underexpression of TIM-3 and blunted galectin-9-induced apoptosis of CD4&#x002B; T cells in rheumatoid arthritis</article-title><source>Inflammation</source><volume>35</volume><fpage>633</fpage><lpage>637</lpage><year>2012</year><pub-id pub-id-type="doi">10.1007/s10753-011-9355-z</pub-id><pub-id pub-id-type="pmid">21717191</pub-id></element-citation></ref>
<ref id="b18-mmr-19-05-3707"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuchroo</surname><given-names>VK</given-names></name><name><surname>Meyers</surname><given-names>JH</given-names></name><name><surname>Umetsu</surname><given-names>DT</given-names></name><name><surname>DeKruyff</surname><given-names>RH</given-names></name></person-group><article-title>TIM family of genes in immunity and tolerance</article-title><source>Adv Immunol</source><volume>91</volume><fpage>227</fpage><lpage>249</lpage><year>2006</year><pub-id pub-id-type="doi">10.1016/S0065-2776(06)91006-2</pub-id><pub-id pub-id-type="pmid">16938542</pub-id></element-citation></ref>
<ref id="b19-mmr-19-05-3707"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Zhou</surname><given-names>T</given-names></name><name><surname>Xiao</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Dou</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Xiao</surname><given-names>H</given-names></name><name><surname>Hou</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><etal/></person-group><article-title>Tim-3 promotes tumor-promoting M2 macrophage polarization by binding to STAT1 and suppressing the STAT1-miR-155 signaling axis</article-title><source>Oncoimmunology</source><volume>5</volume><fpage>e1211219</fpage><year>2016</year><pub-id pub-id-type="doi">10.1080/2162402X.2016.1211219</pub-id><pub-id pub-id-type="pmid">27757304</pub-id><pub-id pub-id-type="pmcid">5048770</pub-id></element-citation></ref>
<ref id="b20-mmr-19-05-3707"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Meng</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Gong</surname><given-names>X</given-names></name></person-group><article-title>miR-330-5p/Tim-3 axis regulates macrophage M2 polarization and insulin resistance in diabetes mice</article-title><source>Mol Immunol</source><volume>95</volume><fpage>107</fpage><lpage>113</lpage><year>2018</year><pub-id pub-id-type="doi">10.1016/j.molimm.2018.02.006</pub-id><pub-id pub-id-type="pmid">29433065</pub-id></element-citation></ref>
<ref id="b21-mmr-19-05-3707"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ying</surname><given-names>H</given-names></name><name><surname>Kang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Zhao</surname><given-names>D</given-names></name><name><surname>Xia</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>F</given-names></name><name><surname>Shi</surname><given-names>L</given-names></name></person-group><article-title>MiR-127 modulates macrophage polarization and promotes lung inflammation and injury by activating the JNK pathway</article-title><source>J Immunol</source><volume>194</volume><fpage>1239</fpage><lpage>1251</lpage><year>2015</year><pub-id pub-id-type="doi">10.4049/jimmunol.1402088</pub-id><pub-id pub-id-type="pmid">25520401</pub-id></element-citation></ref>
<ref id="b22-mmr-19-05-3707"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moorman</surname><given-names>JP</given-names></name><name><surname>Wang</surname><given-names>JM</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Ji</surname><given-names>XJ</given-names></name><name><surname>Ma</surname><given-names>CJ</given-names></name><name><surname>Wu</surname><given-names>XY</given-names></name><name><surname>Jia</surname><given-names>ZS</given-names></name><name><surname>Wang</surname><given-names>KS</given-names></name><name><surname>Yao</surname><given-names>ZQ</given-names></name></person-group><article-title>Tim-3 pathway controls regulatory and effector T cell balance during hepatitis C virus infection</article-title><source>J immunol</source><volume>189</volume><fpage>755</fpage><lpage>766</lpage><year>2012</year><pub-id pub-id-type="doi">10.4049/jimmunol.1200162</pub-id><pub-id pub-id-type="pmid">22706088</pub-id><pub-id pub-id-type="pmcid">3392408</pub-id></element-citation></ref>
<ref id="b23-mmr-19-05-3707"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tandon</surname><given-names>R</given-names></name><name><surname>Giret</surname><given-names>MT</given-names></name><name><surname>Sengupta</surname><given-names>D</given-names></name><name><surname>York</surname><given-names>VA</given-names></name><name><surname>Wiznia</surname><given-names>AA</given-names></name><name><surname>Rosenberg</surname><given-names>MG</given-names></name><name><surname>Kallas</surname><given-names>EG</given-names></name><name><surname>Ndhlovu</surname><given-names>LC</given-names></name><name><surname>Nixon</surname><given-names>DF</given-names></name></person-group><article-title>Age-related expansion of Tim-3 expressing T cells in vertically HIV-1 infected children</article-title><source>PLoS One</source><volume>7</volume><fpage>e45733</fpage><year>2012</year><pub-id pub-id-type="doi">10.1371/journal.pone.0045733</pub-id><pub-id pub-id-type="pmid">23029209</pub-id><pub-id pub-id-type="pmcid">3454343</pub-id></element-citation></ref>
<ref id="b24-mmr-19-05-3707"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Liao</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Luo</surname><given-names>Y</given-names></name><name><surname>Fang</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Zhou</surname><given-names>B</given-names></name><etal/></person-group><article-title>Tim-3-expressing CD4&#x002B; and CD8&#x002B; T cells in human tuberculosis (TB) exhibit polarized effector memory phenotypes and stronger anti-TB effector functions</article-title><source>PLoS Pathog</source><volume>8</volume><fpage>e1002984</fpage><year>2012</year><pub-id pub-id-type="doi">10.1371/journal.ppat.1002984</pub-id><pub-id pub-id-type="pmid">23144609</pub-id><pub-id pub-id-type="pmcid">3493466</pub-id></element-citation></ref>
<ref id="b25-mmr-19-05-3707"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koguchi</surname><given-names>K</given-names></name><name><surname>Anderson</surname><given-names>DE</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>O&#x0027;Connor</surname><given-names>KC</given-names></name><name><surname>Kuchroo</surname><given-names>VK</given-names></name><name><surname>Hafler</surname><given-names>DA</given-names></name></person-group><article-title>Dysregulated T cell expression of TIM3 in multiple sclerosis</article-title><source>J Exp Med</source><volume>203</volume><fpage>1413</fpage><lpage>1418</lpage><year>2006</year><pub-id pub-id-type="doi">10.1084/jem.20060210</pub-id><pub-id pub-id-type="pmid">16754722</pub-id><pub-id pub-id-type="pmcid">2118310</pub-id></element-citation></ref>
<ref id="b26-mmr-19-05-3707"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villaggio</surname><given-names>B</given-names></name><name><surname>Soldano</surname><given-names>S</given-names></name><name><surname>Cutolo</surname><given-names>M</given-names></name></person-group><article-title>1,25-dihydroxyvitamin D3 downregulates aromatase expression and inflammatory cytokine production in human macrophages</article-title><source>Clin Exp Rheumatol</source><volume>30</volume><fpage>934</fpage><lpage>938</lpage><year>2012</year><pub-id pub-id-type="pmid">23253631</pub-id></element-citation></ref>
<ref id="b27-mmr-19-05-3707"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chambers</surname><given-names>ES</given-names></name><name><surname>Suwannasaen</surname><given-names>D</given-names></name><name><surname>Mann</surname><given-names>EH</given-names></name><name><surname>Urry</surname><given-names>Z</given-names></name><name><surname>Richards</surname><given-names>DF</given-names></name><name><surname>Lertmemongkolchai</surname><given-names>G</given-names></name><name><surname>Hawrylowicz</surname><given-names>CM</given-names></name></person-group><article-title>1&#x03B1;,25-dihydroxyvitamin D3 in combination with transforming growth factor-&#x03B2; increases the frequency of Foxp3<sup>&#x002B;</sup> regulatory T cells through preferential expansion and usage of interleukin-2</article-title><source>Immunology</source><volume>143</volume><fpage>52</fpage><lpage>60</lpage><year>2014</year><pub-id pub-id-type="doi">10.1111/imm.12289</pub-id><pub-id pub-id-type="pmid">24673126</pub-id><pub-id pub-id-type="pmcid">4137955</pub-id></element-citation></ref>
<ref id="b28-mmr-19-05-3707"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karmali</surname><given-names>R</given-names></name><name><surname>Hewison</surname><given-names>M</given-names></name><name><surname>Rayment</surname><given-names>N</given-names></name><name><surname>Farrow</surname><given-names>SM</given-names></name><name><surname>Brennan</surname><given-names>A</given-names></name><name><surname>Katz</surname><given-names>DR</given-names></name><name><surname>O&#x0027;Riordan</surname><given-names>JL</given-names></name></person-group><article-title>1,25(OH)2D3 regulates c-myc mRNA levels in tonsillar T lymphocytes</article-title><source>Immunology</source><volume>74</volume><fpage>589</fpage><lpage>593</lpage><year>1991</year><pub-id pub-id-type="pmid">1783418</pub-id><pub-id pub-id-type="pmcid">1384765</pub-id></element-citation></ref>
<ref id="b29-mmr-19-05-3707"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Livak</surname><given-names>KJ</given-names></name><name><surname>Schmittgen</surname><given-names>TD</given-names></name></person-group><article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method</article-title><source>Methods</source><volume>25</volume><fpage>402</fpage><lpage>408</lpage><year>2001</year><pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id><pub-id pub-id-type="pmid">11846609</pub-id></element-citation></ref>
<ref id="b30-mmr-19-05-3707"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNelis</surname><given-names>JC</given-names></name><name><surname>Olefsky</surname><given-names>JM</given-names></name></person-group><article-title>Macrophages, immunity, and metabolic disease</article-title><source>Immunity</source><volume>41</volume><fpage>36</fpage><lpage>48</lpage><year>2014</year><pub-id pub-id-type="doi">10.1016/j.immuni.2014.05.010</pub-id><pub-id pub-id-type="pmid">25035952</pub-id></element-citation></ref>
<ref id="b31-mmr-19-05-3707"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saeed</surname><given-names>S</given-names></name><name><surname>Quintin</surname><given-names>J</given-names></name><name><surname>Kerstens</surname><given-names>HH</given-names></name><name><surname>Rao</surname><given-names>NA</given-names></name><name><surname>Aghajanirefah</surname><given-names>A</given-names></name><name><surname>Matarese</surname><given-names>F</given-names></name><name><surname>Cheng</surname><given-names>SC</given-names></name><name><surname>Ratter</surname><given-names>J</given-names></name><name><surname>Berentsen</surname><given-names>K</given-names></name><name><surname>van der Ent</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity</article-title><source>Science</source><volume>345</volume><fpage>1251086</fpage><year>2014</year><pub-id pub-id-type="doi">10.1126/science.1251086</pub-id><pub-id pub-id-type="pmid">25258085</pub-id><pub-id pub-id-type="pmcid">4242194</pub-id></element-citation></ref>
<ref id="b32-mmr-19-05-3707"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shojadoost</surname><given-names>B</given-names></name><name><surname>Behboudi</surname><given-names>S</given-names></name><name><surname>Villanueva</surname><given-names>AI</given-names></name><name><surname>Brisbin</surname><given-names>JT</given-names></name><name><surname>Ashkar</surname><given-names>AA</given-names></name><name><surname>Sharif</surname><given-names>S</given-names></name></person-group><article-title>Vitamin D3 modulates the function of chicken macrophages</article-title><source>Res Vet Sci</source><volume>100</volume><fpage>45</fpage><lpage>51</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.rvsc.2015.03.009</pub-id><pub-id pub-id-type="pmid">25814176</pub-id></element-citation></ref>
<ref id="b33-mmr-19-05-3707"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>K</given-names></name><name><surname>You</surname><given-names>Y</given-names></name><name><surname>Swier</surname><given-names>V</given-names></name><name><surname>Tang</surname><given-names>L</given-names></name><name><surname>Radwan</surname><given-names>MM</given-names></name><name><surname>Pandya</surname><given-names>AN</given-names></name><name><surname>Agrawal</surname><given-names>DK</given-names></name></person-group><article-title>Vitamin D protects against atherosclerosis via regulation of cholesterol efflux and macrophage polarization in hypercholesterolemic swine</article-title><source>Arterioscler Thromb Vasc Biol</source><volume>35</volume><fpage>2432</fpage><lpage>2442</lpage><year>2015</year><pub-id pub-id-type="doi">10.1161/ATVBAHA.115.306132</pub-id><pub-id pub-id-type="pmid">26381871</pub-id><pub-id pub-id-type="pmcid">4618721</pub-id></element-citation></ref>
<ref id="b34-mmr-19-05-3707"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>AC</given-names></name><name><surname>Joller</surname><given-names>N</given-names></name><name><surname>Kuchroo</surname><given-names>VK</given-names></name></person-group><article-title>Lag-3, Tim-3, and TIGIT: Co-inhibitory receptors with specialized functions in immune regulation</article-title><source>Immunity</source><volume>44</volume><fpage>989</fpage><lpage>1004</lpage><year>2016</year><pub-id pub-id-type="doi">10.1016/j.immuni.2016.05.001</pub-id><pub-id pub-id-type="pmid">27192565</pub-id><pub-id pub-id-type="pmcid">4942846</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-mmr-19-05-3707" position="float">
<label>Figure 1.</label>
<caption><p>Confocal microscopy imaging. The morphology of live RAW264.7 cells at magnifications, &#x00D7;100 and &#x00D7;200 were observed using confocal microscopy.</p></caption>
<graphic xlink:href="MMR-19-05-3707-g00.tif"/>
</fig>
<fig id="f2-mmr-19-05-3707" position="float">
<label>Figure 2.</label>
<caption><p>Effects of 1,25(OH)<sub>2</sub>D3 on macrophage at 10<sup>&#x2212;8</sup> and 10<sup>&#x2212;7</sup> M concentrations. RAW264.7 cells were cultured at different 1,25(OH)<sub>2</sub>D3 concentrations (0, 10<sup>&#x2212;8</sup> and 10<sup>&#x2212;7</sup> M). ELISAs were used to detect the (A) IL-6, (B) IL-10, (C) TNF-&#x03B1; and (D) TGF-&#x03B2; protein expression levels among different groups. (E) Tim-3, (F) NOS2 and (G) CD206 protein levels were assessed by western blot analysis. (H) Representative western blot image. (I) Tim-3, (J) NOS2 and (K) CD206 mRNA levels were analyzed by reverse transcription quantitative polymerase chain reaction assays. &#x002A;P&#x003C;0.05 and &#x002A;&#x002A;P&#x003C;0.01 vs. control group; <sup>#</sup>P&#x003C;0.05 and <sup>##</sup>P&#x003C;0.01 vs. 10<sup>&#x2212;8</sup> M group. Data are presented as mean &#x00B1; standard deviation (n=5). 1,25(OH)<sub>2</sub>D3, 1,25-dihydroxy-vitamin D3; IL, interleukin; TNF-&#x03B1;, tumor necrosis factor &#x03B1;; TGF-&#x03B2;, transforming growth factor; Tim-3, T-cell Immunoglobulin-mucin-3; NOS2, nitric oxide synthase, inducible; CD206, macrophage mannose receptor 1.</p></caption>
<graphic xlink:href="MMR-19-05-3707-g01.tif"/>
</fig>
<fig id="f3-mmr-19-05-3707" position="float">
<label>Figure 3.</label>
<caption><p>Effects of Tim-3 gene silencing on macrophages. ELISAs were applied to detect the (A) IL-6, (B) IL-10, (C) TNF-&#x03B1; and (D) TGF-&#x03B2; levels in the control, NC and siTim-3 groups. (E) Tim-3, (F) NOS2 and (G) CD206 protein levels were assessed by western blot analysis. (H) Representative western blot image. (I) Tim-3, (J) NOS2 and (K) CD206 mRNA levels were analyzed by reverse transcription quantitative polymerase chain reaction assays. &#x002A;&#x002A;P&#x003C;0.01 vs. control group; <sup>##</sup>P&#x003C;0.01 vs. NC group. Data are presented as mean &#x00B1; standard deviation (n=5). IL, interleukin; TNF-&#x03B1;, tumor necrosis factor &#x03B1;; TGF-&#x03B2;, transforming growth factor; Tim-3, T-cell Immunoglobulin-mucin-3; NOS2, nitric oxide synthase, inducible; CD206, macrophage mannose receptor 1; si, small interfering.</p></caption>
<graphic xlink:href="MMR-19-05-3707-g02.tif"/>
</fig>
<fig id="f4-mmr-19-05-3707" position="float">
<label>Figure 4.</label>
<caption><p>Effects of Tim-3 gene overexpression on macrophages. The levels of (A) IL-6, (B) IL-10, (C) TNF-&#x03B1; and (D) TGF-&#x03B2; in the control, NC and pTim-3 groups were detected using ELISAs. (E) Tim-3, (F) NOS2 and (G) CD206 protein levels were assessed by western blot analysis. (H) Representative western blot image. (I) Tim-3, (J) NOS2 and (K) CD206 mRNA levels were analyzed by reverse transcription quantitative polymerase chain reaction assays. &#x002A;&#x002A;P&#x003C;0.01 vs. control group; <sup>##</sup>P&#x003C;0.01 vs. NC group. Data are presented as mean &#x00B1; standard deviation (n=5). IL, interleukin; TNF-&#x03B1;, tumor necrosis factor &#x03B1;; TGF-&#x03B2;, transforming growth factor; Tim-3, T-cell Immunoglobulin-mucin-3; NOS2, nitric oxide synthase, inducible; CD206, macrophage mannose receptor 1; pTim-3, overexpressing Tim-3 plasmid.</p></caption>
<graphic xlink:href="MMR-19-05-3707-g03.tif"/>
</fig>
<fig id="f5-mmr-19-05-3707" position="float">
<label>Figure 5.</label>
<caption><p>Effects of 1,25(OH)<sub>2</sub>D3 on macrophages with different Tim-3 expression levels. RAW264.7 macrophages with silenced Tim-3 expression and Tim-3 overexpression were cultured with 10<sup>&#x2212;7</sup> M 1,25(OH)<sub>2</sub>D3. ELISAs were used to assess the levels of (A) IL-6, (B) IL-10, (C) TNF-&#x03B1; and (D) TGF-&#x03B2; in the control group. (E) Tim-3, (F) CD206 and (G) NOS2 protein levels were assessed by western blot analysis. (H) Representative western blot image. (I) Tim-3, (J) NOS2 and (K) CD206 mRNA levels were analyzed by reverse transcription quantitative polymerase chain reaction assays. &#x002A;P&#x003C;0.05 and &#x002A;&#x002A;P&#x003C;0.01 vs. control group; <sup>&#x002B;</sup>P&#x003C;0.05; <sup>&#x002B;&#x002B;</sup>P&#x003C;0.01; <sup>##</sup>P&#x003C;0.01; <sup>&#x0026;&#x0026;</sup>P&#x003C;0.01. Data are presented as mean &#x00B1; standard deviation (n=5). 1,25(OH)<sub>2</sub>D3, 1,25-dihydroxy-vitamin D3; IL, interleukin; TNF-&#x03B1;, tumor necrosis factor &#x03B1;; TGF-&#x03B2;, transforming growth factor; Tim-3, T-cell Immunoglobulin-mucin-3; NOS2, nitric oxide synthase, inducible; CD206, macrophage mannose receptor 1; pTim-3, overexpressing Tim-3 plasmid; si, small interfering.</p></caption>
<graphic xlink:href="MMR-19-05-3707-g04.tif"/>
</fig>
<table-wrap id="tI-mmr-19-05-3707" position="float">
<label>Table I.</label>
<caption><p>Sequences of primers.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom">Primer name</th>
<th align="center" valign="bottom">Sequence (5&#x2032;-3&#x2032;)</th>
<th align="center" valign="bottom">Product size, bp</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Tim-3-forward</td>
<td align="center" valign="top">CTCCAAGAACCCTAACCACG</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">Tim-3-reverse</td>
<td align="center" valign="top">AGCCCATGTGGAAATTTTTG</td>
<td align="center" valign="top">288</td>
</tr>
<tr>
<td align="left" valign="top">NOS2-forward</td>
<td align="center" valign="top">CAGCTGGGCTGTACAAACCTT</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">NOS2-reverse</td>
<td align="center" valign="top">CATTGGAAGTGAAGCGTTTCG</td>
<td align="center" valign="top">245</td>
</tr>
<tr>
<td align="left" valign="top">CD206-forward</td>
<td align="center" valign="top">TTCGGACACCCATC-GGAATTT</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">CD206-reverse</td>
<td align="center" valign="top">CACAAGCGCTGCGTGGAT</td>
<td align="center" valign="top">262</td>
</tr>
<tr>
<td align="left" valign="top">&#x03B2;-actin-forward</td>
<td align="center" valign="top">GCTGCGTGTGGCCCCTGAG</td>
<td/>
</tr>
<tr>
<td align="left" valign="top">&#x03B2;-actin-reverse</td>
<td align="center" valign="top">ACGCAGGATGGCATGAGGGA</td>
<td align="center" valign="top">252</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn1-mmr-19-05-3707"><p>Tim-3, T-cell Immunoglobulin-mucin-3; NOS2, nitric oxide synthase, inducible; CD206, macrophage mannose receptor 1.</p></fn>
</table-wrap-foot>
</table-wrap>
</floats-group>
</article>